Contract award
SPRING MILL PHARMA INCORPORATED
TO ADVANCE A NOVEL BETA-LACTAMASE INHIBITOR OF PENICILLIN BINDING PROTEINS TARGETING MDR-ACINETOBACTER BAUMANNII.
- PIID
- 75N93020C00016
- Award key
- CONT_AWD_75N93020C00016_7529_-NONE-_-NONE-
- Recipient UEI
- UWZNAK5HJLN7
- Source as of
- —
Current award value
$25,044,8933
Obligated to date
$25,044,8932
Potential with options
$44,503,6143
- Awarding agency
- Department of Health and Human ServicesNational Institutes of Health
- Contractor
- SPRING MILL PHARMA INCORPORATED
- Place of performance
- Malvern, Pennsylvania
- Set-aside
- No set-aside used
- Pricing
- Cost Plus Fixed Fee
- Competition
- Full and Open Competition12 offers received
- Period of performance
- Jul 1, 2020 — Jan 18, 2027Through Jan 18, 2027 if all options are exercised
- Benchmark category
- Unclassified
Transaction history
Every action recorded against this award, in the order the government reported them.
| Mod | Action date | Reason | Obligation | Value at action |
|---|---|---|---|---|
| 0 | Jun 29, 2020 | Initial award | $3,229,128.00 | $25,044,892.75 |
| P00001 | Sep 11, 2020 | B | $0.00 | $25,044,892.75 |
| P00002 | Dec 21, 2021 | B | $0.00 | $25,044,892.75 |
| P00003 | May 26, 2022 | G | $2,954,004.00 | $25,044,892.75 |
| P00004 | Sep 16, 2022 | G | $4,486,144.00 | $25,044,892.75 |
| P00005 | Jan 9, 2023 | B | $0.00 | $25,044,892.75 |
| P00006 | May 16, 2023 | B | $4,711,879.00 | $25,044,892.75 |
| P00007 | Aug 29, 2023 | B | $0.00 | $25,044,892.75 |
| P00008 | Jul 1, 2024 | G | $9,407,873.00 | $25,044,892.75 |
| P00009 | Aug 1, 2024 | B | $0.00 | $25,044,892.75 |
| P00010 | Sep 10, 2024 | B | $0.00 | $25,044,892.75 |
| P00011 | Nov 22, 2024 | B | $0.00 | $25,044,892.75 |
| P00012 | Jul 31, 2025 | C | $255,864.75 | $25,044,892.75 |
| P00013 | Jan 16, 2026 | B | $0.00 | $25,044,892.75 |
| P00014 | Jul 23, 2026 | J | $0.00 | $25,044,892.75 |
Provenance
Which source record produced each displayed rollup figure.
| Field | Source | File | Retrieved | Parser | Artifact hash |
|---|---|---|---|---|---|
| awarding_agency_id | USAspending.gov | — | Aug 10, 2026 | usaspending_contract_csv@2026.08.2 | f65f7563c089 |
| contractor_id | USAspending.gov | — | Aug 10, 2026 | usaspending_contract_csv@2026.08.2 | f65f7563c089 |
| current_award_value | USAspending.gov | — | Aug 10, 2026 | usaspending_contract_csv@2026.08.2 | f65f7563c089 |
| naics_code | USAspending.gov | — | Aug 10, 2026 | usaspending_contract_csv@2026.08.2 | f65f7563c089 |
| potential_award_value | USAspending.gov | — | Aug 10, 2026 | usaspending_contract_csv@2026.08.2 | f65f7563c089 |
| psc_code | USAspending.gov | — | Aug 10, 2026 | usaspending_contract_csv@2026.08.2 | f65f7563c089 |
| total_obligated | USAspending.gov | — | Aug 10, 2026 | usaspending_contract_csv@2026.08.2 | f65f7563c089 |
Sources and method
Figures on this page are computed from public federal award records. Numbers are never estimated or generated; where a figure is withheld, the reason is stated rather than filled in.
This page is a record of one federal award, assembled from the transactions the government published against it. Note 1 describes where the rollup came from. Values are award values, not unit prices.
- 1Rollup values derive from 15 transaction records parsed from USAspending.gov, retrieved Aug 10, 2026 by transform awards@2026.08.1.
- 2Obligations are the sum of signed federal action obligations across all transactions; deobligations are negative and remain negative.
- 3Current and potential award values are taken from the latest reported action, not summed across modifications.